MED-ED Revenue and Competitors
Estimated Revenue & Valuation
- MED-ED's estimated annual revenue is currently $8M per year.
- MED-ED's estimated revenue per employee is $148,500
Employee Data
- MED-ED has 54 Employees.
- MED-ED grew their employee count by 10% last year.
MED-ED's People
Name | Title | Email/Phone |
---|---|---|
1 | Director, Distance Learning | Reveal Email/Phone |
2 | Project Manager | Reveal Email/Phone |
3 | Senior Sales Coordinator | Reveal Email/Phone |
MED-ED Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.1M | 11 | N/A | N/A | N/A |
#2 | $20M | 121 | 3% | N/A | N/A |
#3 | $22.9M | 139 | N/A | N/A | N/A |
#4 | $3.3M | 29 | N/A | N/A | N/A |
#5 | $9.5M | 64 | 12% | N/A | N/A |
#6 | $8M | 54 | 10% | N/A | N/A |
#7 | $6.6M | 50 | 9% | N/A | N/A |
#8 | $9.4M | 63 | 15% | N/A | N/A |
#9 | $5.1M | 39 | -11% | N/A | N/A |
#10 | $8M | 54 | N/A | N/A | N/A |
What Is MED-ED?
MED-ED believes that lifelong learning is the cornerstone of professional nursing competence, providing the knowledge necessary to assure optimum patient care and safety. Established in 1983, MED-ED leads the industry in providing nurses with continuing education that elevates their practice by focusing on evidence-based practice and the development of competence and critical thinking skills. Nursing continuing education is provided through seminars, self-directed eLearning courses and hospital consultations. MED-ED is committed to excellence in continuing education and unparalleled customer care. MED-ED meets the rigorous requirements of the American Nurses Credentialing Center (ANCC) as a nationally accredited provider.
keywords:N/AN/A
Total Funding
54
Number of Employees
$8M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15.7M | 54 | -29% | N/A |
#2 | $4.9M | 54 | 6% | N/A |
#3 | $3.5M | 54 | 15% | N/A |
#4 | $3.2M | 54 | 42% | $775M |
#5 | $15M | 54 | 4% | N/A |